{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:39:09Z","timestamp":1786649949751,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Transfusion support is vital for the management of patients with hepatobiliary disease. Repeated blood transfusions increase the risk of alloimmunization, i.e., the development of alloantibodies, which might lead to difficulties in blood crossmatching.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>AIMS:<\/jats:title>\n                    <jats:p>This study aims to: (1) determine the incidence of red blood cell (RBC) alloimmunization and (2) evaluate the associations between antibody development and demographic factors among hepatobiliary patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHOD:<\/jats:title>\n                    <jats:p>ABO blood grouping, antibody screening, antibody identification and crossmatch were done on all patients samples included in the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTINGS AND DESIGN:<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted from February 2021 to September 2021, with a total of 132 samples from hepatobiliary patients. The relationships between RBC alloimmunization in transfused hepatobiliary patients and demographic factors (gender, age, and history of transfusion) were assessed by binary logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Overall, 67.4% of the patients developed alloimmunization. The majority had a single alloantibody (75.2%) and the most frequently identified antibody specificities were anti-E (37.6%), anti-c (12.8%), anti-Mia (14.4%), and anti-Kidd (11.2%). The predominant antibodies were those against the Rh system (58.4%). Female patients recorded the highest incidence of alloimmunization (69.8%). Female patients also demonstrated a higher tendency to produce both anti-E + anti-c than male patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>The prevalence of RBC alloimmunization is high among hepatobiliary patients and it may cause complications requiring multiple transfusions. The number of transfused packed cells has been clearly shown to be proportionally significant with the risk for alloimmunization in hepatobiliary patients. Hence, this study highlights the importance of immunohematology tests before blood transfusion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ajts.ajts_75_22","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T12:27:28Z","timestamp":1734956848000},"page":"286-290","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Red cell alloimmunization in multitransfused hepatobiliary patients at hospital Selayang"],"prefix":"10.4103","volume":"18","author":[{"given":"Prasanthini","family":"Nahendran","sequence":"first","affiliation":[{"name":"Centre for Toxicology and Health Risk Studies, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti Balkis","family":"Budin","sequence":"additional","affiliation":[{"name":"Centre for Diagnostic, Therapeutic and Investigation, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Zakiah Mohd","family":"Saat","sequence":"additional","affiliation":[{"name":"Centre of Community Health, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Faeiz","family":"Yusop","sequence":"additional","affiliation":[{"name":"Department of Pathology, Blood Transfusion Unit, Hospital Selayang, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengku Norita Tengku","family":"Yazid","sequence":"additional","affiliation":[{"name":"Department of Pathology, Blood Transfusion Unit, Hospital Selayang, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Najmi Mohamad","family":"Anuar","sequence":"additional","affiliation":[{"name":"Centre for Toxicology and Health Risk Studies, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"key":"R1-20241224","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.5001\/omj.2020.95","article-title":"Prevalence of red blood cell alloimmunization among transfused chronic kidney disease patients in hospital Universiti Sains Malaysia","volume":"35","author":"Yusoff","year":"2020","journal-title":"Oman Med J"},{"key":"R2-20241224","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000370136","article-title":"Frequency and specificity of red blood cell alloimmunization in chilean transfused patients","volume":"42","author":"Caama\u00f1o","year":"2015","journal-title":"Transfus Med Hemotherapy"},{"key":"R3-20241224","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tmrv.2018.07.002","article-title":"Red blood cell alloimmunization in the pregnant patient","volume":"32","author":"Webb","year":"2018","journal-title":"Transfus Med Rev"},{"key":"R4-20241224","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/0973-6247.75997","article-title":"Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan","volume":"5","author":"Al-Joudi","year":"2011","journal-title":"Asian J Transfus Sci"},{"key":"R5-20241224","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0973-6247.115577","article-title":"Detection of alloimmunization to ensure safer transfusion practice","volume":"7","author":"Sood","year":"2013","journal-title":"Asian J Transfus Sci"},{"key":"R6-20241224","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12288-012-0155-x","article-title":"Incidence of red cell alloantibody among the transfusion recipients of Universiti Kebangsaan Malaysia medical Centre","volume":"29","author":"Yousuf","year":"2013","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R7-20241224","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/0973-6247.187936","article-title":"Alloimmunization in multitransfused liver disease patients: Impact of underlying disease","volume":"10","author":"Bajpai","year":"2016","journal-title":"Asian J Transfus Sci"},{"key":"R8-20241224","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.htct.2018.04.001","article-title":"Red blood cell alloimmunization among hospitalized patients: Transfusion reactions and low alloantibody identification rate","volume":"40","author":"Pessoni","year":"2018","journal-title":"Hematol Transfus Cell Ther"},{"key":"R9-20241224","doi-asserted-by":"crossref","first-page":"111","DOI":"10.21037\/amj.2018.11.02","article-title":"Red blood cell transfusion in the cirrhotic patient with gastrointestinal bleeding","volume":"3","author":"Lam","year":"2019","journal-title":"AME Med J"},{"key":"R10-20241224","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.htct.2017.08.001","article-title":"Clinical and epidemiological profile of alloimmunized and autoimmunized multi-transfused patients against red blood cell antigens in a blood center of minas Gerais","volume":"40","author":"Valle","year":"2018","journal-title":"Hematol Transfus Cell Ther"},{"key":"R11-20241224","doi-asserted-by":"crossref","first-page":"979","DOI":"10.4314\/ahs.v18i4.18","article-title":"Red blood cell alloimmunization in multi-transfused patients with chronic kidney disease in port Harcourt, South-South Nigeria","volume":"18","author":"Obi","year":"2018","journal-title":"Afr Health Sci"},{"key":"R12-20241224","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/vox.13190","article-title":"Transfusion requirements and alloimmunization to red blood cell antigens in orthotopic liver transplantation","volume":"117","author":"Uzuni","year":"2022","journal-title":"Vox Sang"},{"key":"R13-20241224","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.4103\/jfmpc.jfmpc_351_20","article-title":"Analysis of red cell alloimmunization in multi transfused patients at a Tertiary care teaching hospital","volume":"9","author":"Handa","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"R14-20241224","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4038\/sljm.v28i1.96","article-title":"Red cell alloimmunization among haemato-oncologic patients in a teaching hospital in Malaysia","volume":"28","author":"Mohd","year":"2019","journal-title":"Sri Lanka J Med"},{"key":"R15-20241224","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.tp.0000278093.58340.fb","article-title":"Alloimmunization to red cell antigens in liver and multivisceral transplant patients","volume":"84","author":"Shariatmadar","year":"2007","journal-title":"Transplantation"},{"key":"R16-20241224","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1590\/S0100-879X2005000500004","article-title":"Risk factors for alloimmunization by patients with sickle cell disease","volume":"38","author":"Murao","year":"2005","journal-title":"Braz J Med Biol Res"},{"key":"R17-20241224","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/0973-6247.137438","article-title":"Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients","volume":"8","author":"Dhawan","year":"2014","journal-title":"Asian J Transfus Sci"},{"key":"R18-20241224","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5045\/br.2013.48.3.217","article-title":"Unexpected red cell antibody detection by conditional combination of LISS\/Coombs and NaCl\/Enzyme gel tests at a tertiary care hospital in Korea: A 5-year study","volume":"48","author":"Shin","year":"2013","journal-title":"Blood Res"},{"key":"R19-20241224","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1179\/102453308X343419","article-title":"Red cell alloimmunization in a transfused patient population: A study from a tertiary care hospital in North India","volume":"13","author":"Thakral","year":"2008","journal-title":"Hematology"},{"key":"R20-20241224","first-page":"186","article-title":"Determination of red cell antigen alloimmunization and specific type of antibody in multi_transfused liver cirrhosis patient","volume":"12","author":"Qayyum","year":"2018","journal-title":"Journal of Punjab Medical College and Faisalabad Medical University"},{"key":"R21-20241224","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1309\/LM4ZQD8J8HHENONV","article-title":"The importance of antibody detection and identification in the chronically transfused patient","volume":"41","author":"Byrne","year":"2010","journal-title":"Lab Med"},{"key":"R22-20241224","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0973-6247.137433","article-title":"Red cell alloimmunization in transfused patients: A silent epidemic revisited","volume":"8","author":"Pandey","year":"2014","journal-title":"Asian J Transfus Sci"},{"key":"R23-20241224","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/vox.12059","article-title":"A UK single-Centre survey of red cell antibodies in adult patients undergoing liver transplantation","volume":"105","author":"Mushkbar","year":"2013","journal-title":"Vox Sang"},{"key":"R24-20241224","first-page":"95","article-title":"The prevalence of GP Mur and anti-\u201cMia\u201din a tertiary hospital in Peninsula Malaysia","volume":"24","author":"Prathiba","year":"2002","journal-title":"Malays J Pathol"},{"key":"R25-20241224","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1182\/blood-2018-08-833962","article-title":"Transfusion-related red blood cell alloantibodies: Induction and consequences","volume":"133","author":"Tormey","year":"2019","journal-title":"Blood"}],"container-title":["Asian Journal of Transfusion Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_75_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:00:21Z","timestamp":1786647621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_75_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ajts.ajts_75_22","relation":{},"ISSN":["0973-6247","1998-3565"],"issn-type":[{"value":"0973-6247","type":"print"},{"value":"1998-3565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,11]]},"assertion":[{"value":"2022-06-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}